"Papanicolaou Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
| Descriptor ID |
D065006
|
| MeSH Number(s) |
E01.370.225.500.384.100.422 E01.370.225.998.054.422 E04.074.422 E05.200.500.384.100.422 E05.200.998.054.422 E05.242.384.100.422
|
| Concept/Terms |
Papanicolaou Test- Papanicolaou Test
- Test, Papanicolaou
- Pap Test
- Test, Pap
- Pap Smear
- Smear, Pap
- Papanicolaou Smear
- Smear, Papanicolaou
|
Below are MeSH descriptors whose meaning is more general than "Papanicolaou Test".
Below are MeSH descriptors whose meaning is more specific than "Papanicolaou Test".
This graph shows the total number of publications written about "Papanicolaou Test" by people in this website by year, and whether "Papanicolaou Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 0 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papanicolaou Test" by people in Profiles.
-
Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV)?testing. J Am Soc Cytopathol. 2024 May-Jun; 13(3):227-232.
-
Smoking history and adherence to cancer-related recommendations in a primary care setting. Transl Behav Med. 2022 02 16; 12(2):362-367.
-
Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening. J Am Soc Cytopathol. 2021 Jul-Aug; 10(4):399-405.
-
Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas. BMC Womens Health. 2021 01 06; 21(1):11.
-
The Utility of Blind Pap Tests in Young Adults with Developmental Delay: A Pilot Study. J Pediatr Adolesc Gynecol. 2021 Jun; 34(3):400-403.
-
Prevalence of abnormal cervical cancer screening outcomes among women in the United States: results from the National Health Interview Survey, 2018. Am J Obstet Gynecol. 2020 12; 223(6):938-941.
-
Qualitative assessment of knowledge and attitudes towards cervical cancer screening among male Latino immigrants in Houston, Texas. BMC Womens Health. 2020 07 06; 20(1):141.
-
Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus. Am J Obstet Gynecol. 2020 05; 222(5):486.e1-486.e10.
-
Cervical cytology reproducibility and associated clinical and demographic factors. Diagn Cytopathol. 2020 Jan; 48(1):35-42.
-
Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting. Cancer Cytopathol. 2019 Dec; 127(12):757-764.